MiR-4732-3p in Extracellular Vesicles From Mesenchymal Stromal Cells Is Cardioprotective During Myocardial Ischemia
Overview
Authors
Affiliations
Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) are an emerging alternative to cell-based therapies to treat many diseases. However, the complexity of producing homogeneous populations of EVs in sufficient amount hampers their clinical use. To address these limitations, we immortalized dental pulp-derived MSC using a human telomerase lentiviral vector and investigated the cardioprotective potential of a hypoxia-regulated EV-derived cargo microRNA, miR-4732-3p. We tested the compared the capacity of a synthetic miR-4732-3p mimic with EVs to confer protection to cardiomyocytes, fibroblasts and endothelial cells against oxygen-glucose deprivation (OGD). Results showed that OGD-induced cardiomyocytes treated with either EVs or miR-4732-3p showed prolonged spontaneous beating, lowered ROS levels, and less apoptosis. Transfection of the miR-4732-3p mimic was more effective than EVs in stimulating angiogenesis and and in reducing fibroblast differentiation upon transforming growth factor beta treatment. Finally, the miR-4732-3p mimic reduced scar tissue and preserved cardiac function when transplanted intramyocardially in infarcted nude rats. Overall, these results indicate that miR-4732-3p is regulated by hypoxia and exerts cardioprotective actions against ischemic insult, with potential application in cell-free-based therapeutic strategies.
Mesenchymal stem cell-derived extracellular vesicles for cell-free therapy of ocular diseases.
Liu X, Hu L, Liu F Extracell Vesicles Circ Nucl Acids. 2024; 3(2):102-117.
PMID: 39698446 PMC: 11648472. DOI: 10.20517/evcna.2022.08.
Miura Y, Fujii S, Ichinohe T J Radiat Res. 2024; 65(Supplement_1):i80-i87.
PMID: 39679884 PMC: 11647929. DOI: 10.1093/jrr/rrae009.
Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury.
Zhou W, Jiang X, Gao J Asian J Pharm Sci. 2024; 19(6):100965.
PMID: 39640057 PMC: 11617990. DOI: 10.1016/j.ajps.2024.100965.
Moscoso I, Rodriguez-Manero M, Cebro-Marquez M, Vilar-Sanchez M, Serrano-Cruz V, Vidal-Abeijon I Int J Mol Sci. 2024; 25(22).
PMID: 39595980 PMC: 11593668. DOI: 10.3390/ijms252211910.
Amaro-Prellezo E, Gomez-Ferrer M, Hakobyan L, Ontoria-Oviedo I, Peiro-Molina E, Tarazona S Inflamm Regen. 2024; 44(1):25.
PMID: 38807194 PMC: 11134765. DOI: 10.1186/s41232-024-00340-7.